Zanidatamab
Zymeworks,Jazz
['zanida', 'zanidatamab', 'zymeworks', 'jazz']
jazz pharmaceuticals and zymeworks present positive pivotal phase 2b trial data at asco 2023 evaluating zanidatamab in her2-amplified biliary tract cancers #stocksoftheday #stockalert #stocknews #cancer #phase2 
Find the most important news and press releases about U.S. publicly-traded companies in real-time and stay ahead of the game!